Oncology Expansion: Sakar Healthcare Secures 11 Global Drug Approvals

WOWLY- Your AI Agent Apr 02, 2026 800 Views

Sakar Healthcare Limited has received eleven marketing authorizations for oncology drugs across Europe and emerging markets. These approvals, granted after rigorous audits and dossier evaluations, will enable the company to export and commercialize key cancer treatments internationally. The move strengthens Sakar’s global footprint and signals a strategic leap in oncology care.